Local levonorgestrel regulation of androgen receptor and 17β-hydroxysteroid dehydrogenase type 2 expression in human endometrium

被引:38
作者
Burton, KA
Henderson, TA
Hillier, SG
Mason, JI
Habib, F
Brenner, RM
Critchley, HOD
机构
[1] Ctr Reprod Biol, Edinburgh EH16 4SB, Midlothian, Scotland
[2] Western Gen Hosp, Dept Oncol, Edinburgh EH4 2XU, Midlothian, Scotland
[3] Oregon Reg Primate Res Ctr, Div Reprod Sci, Beaverton, OR 97006 USA
关键词
androgen receptor; endometrium; 17 beta-hydroxysteroid dehydrogenase type 2; levonorgestrel;
D O I
10.1093/humrep/deg510
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: The levonorgestrel-releasing intrauterine system (LNG-IUS) is a highly effective contraceptive. However, unscheduled breakthrough bleeding (BTB), leads to discontinuation in a proportion of users. The LNG-IUS down-regulates endometrial progesterone and estrogen receptors and this may play a role in the mechanism responsible for BTB. LNG is an androgenic progestogen and so we examined the regulation of the androgen receptor (AR) in endometrium exposed to intrauterine LNG. Furthermore, as the enzyme 17beta-hydroxysteroid dehydrogenase type 2 (17betaHSD2) regulates intracellular levels of estrogens, progestins and androgens, we evaluated the changes in expression of 17betaHSD2 in the same tissue endometrial samples. METHODS: Immunohistochemistry and real time quantitative RT-PCR were used to compare protein and mRNA expression of AR and 17betaHSD2 in endometrial biopsies from women with normal menstrual cycles and those using a LNG-IUS. RESULTS: Immunohistochemistry showed that AR and 17betaHSD2, which were immunolocalized to the stroma and glands of endometrium respectively, were both suppressed by LNG-IUS treatment, though moderate staining of 17betaHSD2 was evident 1 month after insertion of the LNG-IUS. AR mRNA expression was down-regulated in LNG-exposed endometrium when compared with the proliferative phase of the menstrual cycle. 17betaHSD2 mRNA was significantly increased 3 months (but not 6-12 months) after LNG-IUS insertion. CONCLUSIONS: Endometrial intracellular estradiol levels would have been suppressed by 17betaHSD2 during the first few, but not the later, months of LNG-IUS action, and the lowered endometrial estradiol level may contribute to the frequent BTB evident in the early months of LNG-IUS use. The subsequent decline in 17betaHSD2 would lead to elevated local intracellular estradiol in the later months, when the BTB tends to subside. The suppression of AR by the LNG-IUS may also play a role in BTB, as elevated AR has been associated with amenorrhoea.
引用
收藏
页码:2610 / 2617
页数:8
相关论文
共 34 条
[21]   IMMUNOHISTOCHEMICAL ANALYSIS OF HUMAN UTERINE ESTROGEN AND PROGESTERONE RECEPTORS THROUGHOUT THE MENSTRUAL-CYCLE [J].
LESSEY, BA ;
KILLAM, AP ;
METZGER, DA ;
HANEY, AF ;
GREENE, GL ;
MCCARTY, KS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (02) :334-340
[22]   LEVONORGESTREL-RELEASING INTRAUTERINE-DEVICE [J].
LUUKKAINEN, T ;
LAHTEENMAKI, P ;
TOIVONEN, J .
ANNALS OF MEDICINE, 1990, 22 (02) :85-90
[23]   THE EFFECTS OF AN ANTIPROGESTIN, MIFEPRISTONE, AND AN ANTIESTROGEN, TAMOXIFEN, ON ENDOMETRIAL 17-BETA-HYDROXYSTEROID DEHYDROGENASE AND PROGESTIN AND ESTROGEN-RECEPTORS DURING THE LUTEAL-PHASE OF THE MENSTRUAL-CYCLE - AN IMMUNOHISTOCHEMICAL STUDY [J].
MAENTAUSTA, O ;
SVALANDER, P ;
DANIELSSON, KG ;
BYGDEMAN, M ;
VIHKO, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (04) :913-918
[24]   Androgen, estrogen and progesterone receptor expression in the human uterus during the menstrual cycle [J].
Mertens, HJMM ;
Heineman, MJ ;
Theunissen, PHMH ;
de Jong, FH ;
Evers, JLH .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2001, 98 (01) :58-65
[25]   Cell type-specific expression of 17 beta-hydroxysteroid dehydrogenase type 2 in human placenta and fetal liver [J].
Moghrabi, N ;
Head, JR ;
Andersson, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (11) :3872-3878
[26]   Human 17β-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression and localization in term placenta and in endometrium during the menstrual cycle [J].
Mustonen, MVJ ;
Isomaa, VV ;
Vaskivuo, T ;
Tapanainen, J ;
Poutanen, MH ;
Stenbäck, F ;
Vihko, RK ;
Vihko, PT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (04) :1319-1324
[27]   DATING THE ENDOMETRIAL BIOPSY [J].
NOYES, RW ;
HERTIG, AT ;
ROCK, J .
FERTILITY AND STERILITY, 1950, 1 (01) :3-25
[28]   17β-Hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family;: nomenclature and main characteristics of the 17HSD/KSR enzymes [J].
Peltoketo, H ;
Luu-The, V ;
Simard, J ;
Adamski, J .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1999, 23 (01) :1-11
[29]   ULTRASTRUCTURE OF THE MICROVASCULATURE IN THE HUMAN ENDOMETRIUM THROUGHOUT THE NORMAL MENSTRUAL-CYCLE [J].
ROBERTS, DK ;
PARMLEY, TH ;
WALKER, NJ ;
HORBELT, DV .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 166 (05) :1393-1406
[30]   ENDOMETRIAL MORPHOLOGY DURING LONG-TERM USE OF LEVONORGESTREL-RELEASING INTRAUTERINE-DEVICES [J].
SILVERBERG, SG ;
HAUKKAMAA, M ;
ARKO, H ;
NILSSON, CG ;
LUUKKAINEN, T .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1986, 5 (03) :235-241